OpenLB
Open Library of Bioscience
Advanced Search
Clinical pharmacokinetics
08, 2023;62 (8): 1183-1185.

Comment on: "External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps".

Meng Lv, Shengnan Zhang
Author Information
  1. Meng Lv: Department of Pharmacy, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, China. lvmengyh@126.com. ORCID
  2. Shengnan Zhang: Department of Pharmacy, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, China.
PMID: 37351794 DOI: 10.1007/s40262-023-01271-1

Abstract

No abstract text available.

References

  1. El Hassani M, Marsot A. External evaluation of population pharmacokinetic models for precision dosing: current state and knowledge gaps. Clin Pharmacokinet. 2023;62:533–40. https://doi.org/10.1007/s40262-023-01233-7 . [DOI: 10.1007/s40262-023-01233-7]
  2. Chung E, Sen J, Patel P, Seto W. Population pharmacokinetic models of vancomycin in paediatric patients: a systematic review. Clin Pharmacokinet. 2021;60:985–1001. [DOI: 10.1007/s40262-021-01027-9]
  3. Aljutayli A, Marsot A, Nekka F. An update on population pharmacokinetic analyses of vancomycin, part I: in adults. Clin Pharmacokinet. 2020;59:671–98. [DOI: 10.1007/s40262-020-00866-2]
  4. Aljutayli A, El-Haffaf I, Marsot A, Nekka F. An update on population pharmacokinetic analyses of vancomycin, part II: in pediatric patients. Clin Pharmacokinet. 2022;61:47–70. [DOI: 10.1007/s40262-021-01050-w]
  5. Chen N, Guo J, Xie J, Xu M, Hao X, Ma K, et al. Population pharmacokinetics of polymyxin B: a systematic review. Ann Transl Med. 2022;10:231. [DOI: 10.21037/atm-22-236]
  6. Li ZR, Wang CY, Zhu X, Jiao Z. Population pharmacokinetics of levetiracetam: a systematic review. Clin Pharmacokinet. 2021;60:305–18. [DOI: 10.1007/s40262-020-00963-2]
  7. Zamir A, Hussain I, Ur Rehman A, Ashraf W, Imran I, Saeed H, et al. Clinical pharmacokinetics of metoprolol: a systematic review. Clin Pharmacokinet. 2022;61:1095–114. [DOI: 10.1007/s40262-022-01145-y]
  8. Qin Y, Zhang LL, Ye YR. Parametric population pharmacokinetics of linezolid: a systematic review. Br J Clin Pharmacol. 2022;88:4043–66. [DOI: 10.1111/bcp.15368]
  9. Muda MR, Harun SN, Syed Sulaiman SA, Sheikh Ghadzi SM. Population pharmacokinetics analyses of rifampicin in adult and children populations: a systematic review. Br J Clin Pharmacol. 2022;88:3132–52. [DOI: 10.1111/bcp.15298]
  10. Kiang TK, Sherwin CM, Spigarelli MG, Ensom MH. Fundamentals of population pharmacokinetic modelling: modelling and software. Clin Pharmacokinet. 2012;51:515–25. [DOI: 10.1007/BF03261928]
  11. Cheng Y, Wang CY, Li ZR, Pan Y, Liu MB, Jiao Z. Can population pharmacokinetics of antibiotics be extrapolated? Implications of external evaluations. Clin Pharmacokinet. 2021;60:53–68. [DOI: 10.1007/s40262-020-00937-4]
  12. Hughes JH, Tong DMH, Faldasz JD, Frymoyer A, Keizer RJ. Evaluation of neonatal and paediatric vancomycin pharmacokinetic models and the impact of maturation and serum creatinine covariates in a large multicentre data set. Clin Pharmacokinet. 2023;62:67–76. [DOI: 10.1007/s40262-022-01185-4]
  13. Jiao Z. Basic population pharmacokinetic and pharmacodynamic analysis. 3rd ed. Beijing: Science Press; 2020.
  14. Kanji S, Hayes M, Ling A, Shamseer L, Chant C, Edwards DJ, et al. Reporting guidelines for clinical pharmacokinetic studies: the ClinPK statement. Clin Pharmacokinet. 2015;54:783–95. [DOI: 10.1007/s40262-015-0236-8]

MeSH Term

Humans
Models, Biological
Computer Simulation
Letter Research Support, Non-U.S. Gov't Comment

Word Cloud

Created with Highcharts 10.0.0Commenton:"ExternalEvaluationPopulationPharmacokineticModelsPrecisionDosing:CurrentStateKnowledgeGaps"

Similar Articles

Cited By